Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.06
(-0.44%)
CNY 25.06
(-0.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.19 Billion CNY | 24.13% |
| 2022 | 4.18 Billion CNY | 9.57% |
| 2021 | 3.82 Billion CNY | 44.17% |
| 2020 | 2.64 Billion CNY | 12.32% |
| 2019 | 2.35 Billion CNY | 52.83% |
| 2018 | 1.54 Billion CNY | 19.86% |
| 2017 | 1.28 Billion CNY | -12.68% |
| 2016 | 1.47 Billion CNY | 112.23% |
| 2015 | 694.88 Million CNY | 27.47% |
| 2014 | 545.12 Million CNY | 4.38% |
| 2013 | 522.23 Million CNY | 21.65% |
| 2012 | 429.27 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.16 Billion CNY | 0.74% |
| 2024 Q3 | 5.28 Billion CNY | 2.29% |
| 2024 Q1 | 5.12 Billion CNY | -1.31% |
| 2023 FY | 5.19 Billion CNY | 24.13% |
| 2023 Q4 | 5.19 Billion CNY | 5.98% |
| 2023 Q3 | 4.9 Billion CNY | 3.07% |
| 2023 Q2 | 4.75 Billion CNY | 1.87% |
| 2023 Q1 | 4.66 Billion CNY | 11.55% |
| 2022 FY | 4.18 Billion CNY | 9.57% |
| 2022 Q4 | 4.18 Billion CNY | 2.97% |
| 2022 Q3 | 4.06 Billion CNY | 2.5% |
| 2022 Q2 | 3.96 Billion CNY | 2.99% |
| 2022 Q1 | 3.85 Billion CNY | 0.8% |
| 2021 Q4 | 3.82 Billion CNY | -1.26% |
| 2021 Q2 | 3.79 Billion CNY | 38.56% |
| 2021 FY | 3.82 Billion CNY | 44.17% |
| 2021 Q1 | 2.73 Billion CNY | 3.35% |
| 2021 Q3 | 3.86 Billion CNY | 1.97% |
| 2020 Q2 | 2.52 Billion CNY | 1.1% |
| 2020 Q3 | 2.63 Billion CNY | 4.41% |
| 2020 Q1 | 2.49 Billion CNY | 5.88% |
| 2020 Q4 | 2.64 Billion CNY | 0.49% |
| 2020 FY | 2.64 Billion CNY | 12.32% |
| 2019 Q3 | 2.58 Billion CNY | 61.61% |
| 2019 FY | 2.35 Billion CNY | 52.83% |
| 2019 Q4 | 2.35 Billion CNY | -8.83% |
| 2019 Q2 | 1.6 Billion CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 1.54 Billion CNY | 19.86% |
| 2018 Q2 | 1.41 Billion CNY | 0.0% |
| 2018 Q4 | 1.54 Billion CNY | 0.0% |
| 2017 FY | 1.28 Billion CNY | -12.68% |
| 2016 FY | 1.47 Billion CNY | 112.23% |
| 2015 Q3 | 671.29 Million CNY | 0.0% |
| 2015 Q4 | 694.88 Million CNY | 3.51% |
| 2015 FY | 694.88 Million CNY | 27.47% |
| 2014 FY | 545.12 Million CNY | 4.38% |
| 2013 FY | 522.23 Million CNY | 21.65% |
| 2012 FY | 429.27 Million CNY | 0.0% |